These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2525101)

  • 1. Inhaled corticosteroids can modulate the immunopathogenesis of pulmonary sarcoidosis.
    Spiteri MA; Newman SP; Clarke SW; Poulter LW
    Eur Respir J; 1989 Mar; 2(3):218-24. PubMed ID: 2525101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled budesonide influences cellular and biochemical abnormalities in pulmonary sarcoidosis.
    Erkkilä S; Fröseth B; Hellström PE; Kaltiokallio K; Taskinen E; Viljanen A; Viljanen B; Selroos O
    Sarcoidosis; 1988 Sep; 5(2):106-10. PubMed ID: 2852389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled budesonide in pulmonary sarcoidosis: a double-blind, placebo-controlled study. Dutch Study Group on Pulmonary Sarcoidosis.
    Alberts C; van der Mark TW; Jansen HM
    Eur Respir J; 1995 May; 8(5):682-8. PubMed ID: 7656936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and functional changes in alveolar macrophages contribute to the pathogenesis of pulmonary sarcoidosis.
    Spiteri MA; Clarke SW; Poulter LW
    Clin Exp Immunol; 1988 Dec; 74(3):359-64. PubMed ID: 2466589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled corticosteroids and pulmonary sarcoidosis.
    Selroos O
    Sarcoidosis; 1988 Sep; 5(2):104-5. PubMed ID: 3227182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta2-Adrenoceptor desensitization in human alveolar macrophages induced by inhaled terbutaline in vivo is not counteracted by budesonide.
    Zetterlund A; Hjemdahl P; Larsson K
    Clin Sci (Lond); 2001 Apr; 100(4):451-7. PubMed ID: 11256987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled budesonide for maintenance treatment of pulmonary sarcoidosis.
    Selroos O; Löfroos AB; Pietinalho A; Niemistö M; Riska H
    Sarcoidosis; 1994 Sep; 11(2):126-31. PubMed ID: 7809497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of budesonide aerosol in ventilator-dependent preterm babies: a preliminary report.
    Arnon S; Grigg J; Silverman M
    Pediatr Pulmonol; 1996 Apr; 21(4):231-5. PubMed ID: 9121852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alveolar macrophages that suppress T-cell responses may be crucial to the pathogenetic outcome of pulmonary sarcoidosis.
    Spiteri MA; Clarke SW; Poulter LW
    Eur Respir J; 1992 Apr; 5(4):394-403. PubMed ID: 1532939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled budesonide vs prednisone in the maintenance treatment of pulmonary sarcoidosis.
    Zych D; Pawlicka L; Zielinski J
    Sarcoidosis; 1993 Mar; 10(1):56-61. PubMed ID: 8134718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proliferation of alveolar macrophages in pulmonary sarcoidosis correlates with markers of lymphocyte activity in bronchoalveolar lavage fluid].
    Barth J; Kreipe H; Kiemle-Kallee J; Radzun HJ; Petermann W
    Pneumologie; 1990 Feb; 44 Suppl 1():224-5. PubMed ID: 1973297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered immunological reactivity in alveolar macrophages from patients with sarcoidosis.
    Gallagher RB; Guckian M; van Breda A; Odlum C; Fitzgerald MX; Feighery C
    Eur Respir J; 1988 Feb; 1(2):153-60. PubMed ID: 2966072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis.
    Hance AJ; Douches S; Winchester RJ; Ferrans VJ; Crystal RG
    J Immunol; 1985 Jan; 134(1):284-92. PubMed ID: 3964815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No effect of high-dose inhaled steroids in pulmonary sarcoidosis: a double-blind, placebo-controlled study.
    Milman N; Graudal N; Grode G; Munch E
    J Intern Med; 1994 Sep; 236(3):285-90. PubMed ID: 8077885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids.
    Shapiro GG; Mendelson LM; Pearlman DS
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):633-40. PubMed ID: 11428735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis.
    Baughman RP; Lower EE
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 1):1268-71. PubMed ID: 2252243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oxygen radical production by alveolar macrophages in sarcoidosis in relation to activity status of bronchoalveolar lavage lymphocytes].
    Strausz J; Müller-Quernheim J; Steppling H; Nagel M; Ferlinz R
    Pneumologie; 1990 Feb; 44 Suppl 1():222-3. PubMed ID: 2367371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.
    Robinson BW; McLemore TL; Crystal RG
    J Clin Invest; 1985 May; 75(5):1488-95. PubMed ID: 3923038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interleukin 1 secretion from alveolar macrophages in pulmonary sarcoidosis].
    Barth J; Kreipe H; Radzun HJ; Petermann W
    Pneumologie; 1990 Feb; 44 Suppl 1():215-6. PubMed ID: 2367368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.
    Hunninghake GW
    Am Rev Respir Dis; 1984 Apr; 129(4):569-72. PubMed ID: 6608889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.